Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Human prothrombin complex - Octapharma

Next Previous
X
Search
Drug Profile

Human prothrombin complex - Octapharma

Alternative Names: 4 Factor Prothrombin Concentrate Complex - Octapharma; 4-Factor PCC - Octapharma; 4F PCC - Octapharma; BALFAXAR; Four-factor prothrombin complex concentrate; Ocplex; Octaplex; Pronativ

Latest Information Update: 20 Aug 2024

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Octapharma
  • Class Antihaemorrhagics; Biological factors; Blood coagulation factors; Proteins
  • Mechanism of Action Factor IX stimulants; Factor VII stimulants; Factor X stimulants; Protein C inhibitors; Prothrombin stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Surgical blood loss
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Surgical blood loss
  • Phase III Haemorrhage

Most Recent Events

  • 13 Aug 2024 Launched for Surgical blood loss in USA (IV)
  • 28 Jun 2024 Octapharma completes a phase III trial in Surgical blood loss in USA, and Canada (IV) (NCT05523297)
  • 26 Jul 2023 Registered for Surgical blood loss in USA (IV)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top